Bone Biologics (BBLG) Competitors $2.31 -0.54 (-18.95%) Closing price 04:00 PM EasternExtended Trading$2.28 -0.02 (-1.08%) As of 06:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock BBLG vs. NXL, IINN, BTCY, DHAI, INBS, MHUA, TNON, CODX, XAIR, and LYRAShould you be buying Bone Biologics stock or one of its competitors? The main competitors of Bone Biologics include Nexalin Technology (NXL), Inspira Technologies OXY B.H.N. (IINN), Biotricity (BTCY), DIH Holding US (DHAI), Intelligent Bio Solutions (INBS), Meihua International Medical Technologies (MHUA), Tenon Medical (TNON), Co-Diagnostics (CODX), Beyond Air (XAIR), and Lyra Therapeutics (LYRA). These companies are all part of the "medical equipment" industry. Bone Biologics vs. Its Competitors Nexalin Technology Inspira Technologies OXY B.H.N. Biotricity DIH Holding US Intelligent Bio Solutions Meihua International Medical Technologies Tenon Medical Co-Diagnostics Beyond Air Lyra Therapeutics Nexalin Technology (NASDAQ:NXL) and Bone Biologics (NASDAQ:BBLG) are both small-cap medical equipment companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and media sentiment. Does the media refer more to NXL or BBLG? In the previous week, Nexalin Technology and Nexalin Technology both had 1 articles in the media. Bone Biologics' average media sentiment score of 0.00 beat Nexalin Technology's score of -1.00 indicating that Bone Biologics is being referred to more favorably in the news media. Company Overall Sentiment Nexalin Technology Negative Bone Biologics Neutral Do institutionals & insiders hold more shares of NXL or BBLG? 0.6% of Nexalin Technology shares are held by institutional investors. Comparatively, 34.3% of Bone Biologics shares are held by institutional investors. 25.3% of Nexalin Technology shares are held by insiders. Comparatively, 6.1% of Bone Biologics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is NXL or BBLG more profitable? Bone Biologics has a net margin of 0.00% compared to Nexalin Technology's net margin of -5,057.14%. Bone Biologics' return on equity of -100.58% beat Nexalin Technology's return on equity.Company Net Margins Return on Equity Return on Assets Nexalin Technology-5,057.14% -209.20% -186.87% Bone Biologics N/A -100.58%-93.31% Do analysts recommend NXL or BBLG? Nexalin Technology currently has a consensus price target of $5.00, suggesting a potential upside of 498.01%. Given Nexalin Technology's stronger consensus rating and higher possible upside, research analysts plainly believe Nexalin Technology is more favorable than Bone Biologics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nexalin Technology 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Bone Biologics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has preferable earnings & valuation, NXL or BBLG? Bone Biologics has lower revenue, but higher earnings than Nexalin Technology. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNexalin Technology$174.81K83.31-$7.61M-$0.76-1.10Bone BiologicsN/AN/A-$4.11MN/AN/A Which has more volatility & risk, NXL or BBLG? Nexalin Technology has a beta of 3.68, indicating that its stock price is 268% more volatile than the S&P 500. Comparatively, Bone Biologics has a beta of 0.65, indicating that its stock price is 35% less volatile than the S&P 500. SummaryNexalin Technology and Bone Biologics tied by winning 6 of the 12 factors compared between the two stocks. Get Bone Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for BBLG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BBLG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BBLG vs. The Competition Export to ExcelMetricBone BiologicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.16M$3.16B$5.77B$9.93BDividend YieldN/A2.28%6.67%4.52%P/E RatioN/A21.1075.6026.68Price / SalesN/A467.69555.18213.69Price / CashN/A45.1137.1158.92Price / Book0.289.8611.446.09Net Income-$4.11M-$53.47M$3.28B$266.14M7 Day Performance7.44%2.89%0.84%0.27%1 Month Performance-14.13%8.62%7.15%4.13%1 Year Performance-68.95%13.69%59.65%23.93% Bone Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BBLGBone Biologics0.7306 of 5 stars$2.31-18.9%N/A-61.1%$4.16MN/A0.002News CoverageNXLNexalin Technology2.0494 of 5 stars$0.85+1.5%$5.00+490.5%-7.8%$14.53M$174.81K-1.113Negative NewsShort Interest ↑IINNInspira Technologies OXY B.H.N.3.3259 of 5 stars$1.18+3.5%$2.00+69.5%-0.9%$14.39MN/A0.0020Short Interest ↓Analyst RevisionBTCYBiotricityN/A$0.57-12.9%N/A+54.2%$14.18M$12.06M-0.5340Gap UpHigh Trading VolumeDHAIDIH Holding US1.2435 of 5 stars$0.27-4.0%N/A-89.9%$13.25M$64.47M-0.90N/ANews CoverageShort Interest ↓Gap DownINBSIntelligent Bio Solutions0.1011 of 5 stars$1.46-0.5%N/A+16.9%$13.20M$3.05M-0.7110Positive NewsMHUAMeihua International Medical Technologies1.748 of 5 stars$0.43+4.9%N/A-62.5%$13.08M$96.91M0.00620Short Interest ↓TNONTenon Medical1.3265 of 5 stars$1.31-5.8%$5.50+319.8%+162.1%$12.34M$2.95M-0.058News CoverageShort Interest ↑CODXCo-Diagnostics4.2434 of 5 stars$0.31-1.4%$5.50+1,660.6%-75.3%$12.20M$3.91M-0.27100XAIRBeyond Air4.1768 of 5 stars$2.25-1.3%$11.00+388.9%-75.1%$11.92M$3.70M-0.1970LYRALyra Therapeutics2.8653 of 5 stars$7.19+3.9%$100.00+1,290.8%-51.0%$11.38M$1.53M-0.2550 Related Companies and Tools Related Companies NXL Alternatives IINN Alternatives BTCY Alternatives DHAI Alternatives INBS Alternatives MHUA Alternatives TNON Alternatives CODX Alternatives XAIR Alternatives LYRA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BBLG) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bone Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bone Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
